Arcutis Biotherapeutics, Inc. · NASDAQ:ARQT
Arcutis Biotherapeutics, Inc. shareholders
As of Jun 30, 2026, 263 institutions reported holding Arcutis Biotherapeutics, Inc. Largest: Montanova Capital, LLC, BlackRock and Frazier Life Sciences Management, L.P. New holders, exits, insiders and big stakes, each with its filing.
| Holder | Shares | % of Arcutis Biotherapeutics, Inc. | Change | Filed |
|---|---|---|---|---|
| Montanova Capital, LLC | 12.4M | +110K | Aug 14, 2026 | |
| BlackRock | 10.5M | +1.35M | Aug 7, 2026 | |
| Frazier Life Sciences Management, L.P. | 9.87M | no change | Aug 14, 2026 | |
| Vanguard | 8.4M | +650K | Aug 13, 2026 | |
| Rubric Capital Management LP | 8.27M | no change | Aug 14, 2026 | |
| Polar Capital Holdings Plc | 6.61M | +940K | Aug 14, 2026 | |
| State Street | 5.82M | −473K | Aug 7, 2026 | |
| Morgan Stanley | 4.45M | +232K | Aug 13, 2026 | |
| Jennison Associates LLC | 4.22M | −762K | Aug 3, 2026 | |
| D. E. Shaw & Co., Inc. | 3.95M | +1.45M | Aug 14, 2026 |